DarioHealth Corp. financial data

Symbol
DRIO on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 280% % 10%
Quick Ratio 34% % 15%
Return On Equity -59% % 18%
Return On Assets -37% % 9.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,768,184 shares -80%
Common Stock, Shares, Outstanding 6,768,184 shares -78%
Entity Public Float $31,031,352 USD -68%
Common Stock, Value, Issued $4,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 3,138,106 shares 55%
Weighted Average Number of Shares Outstanding, Diluted 3,138,106 shares 55%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $16,438,000 USD -29%
General and Administrative Expense $16,103,000 USD -23%
Operating Income (Loss) $39,761,000 USD 34%
Nonoperating Income (Expense) $2,377,000 USD -122%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $42,138,000 USD 15%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $42,315,000 USD 11%
Earnings Per Share, Basic -1 USD/shares -123%
Earnings Per Share, Diluted -1 USD/shares -123%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $31,907,000 USD 105%
Inventory, Net $4,869,000 USD 2.7%
Other Assets, Current $289,000 USD 16%
Assets, Current $42,185,000 USD 43%
Property, Plant and Equipment, Net $578,000 USD -53%
Operating Lease, Right-of-Use Asset $746,000 USD -43%
Intangible Assets, Net (Excluding Goodwill) $16,405,000 USD -19%
Goodwill $57,427,000 USD 0%
Assets $117,727,000 USD 7.1%
Employee-related Liabilities, Current $4,112,000 USD 0.96%
Accrued Liabilities, Current $1,940,000 USD -13%
Contract with Customer, Liability, Current $860,000 USD -23%
Liabilities, Current $9,279,000 USD -51%
Deferred Income Tax Liabilities, Net $4,174,000 USD 72%
Operating Lease, Liability, Noncurrent $579,000 USD -44%
Other Liabilities, Noncurrent $74,000 USD 51%
Retained Earnings (Accumulated Deficit) $441,826,000 USD -17%
Stockholders' Equity Attributable to Parent $74,934,000 USD 28%
Liabilities and Equity $117,727,000 USD 7.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $6,673,000 USD 49%
Net Cash Provided by (Used in) Financing Activities $6,815,000 USD -66%
Net Cash Provided by (Used in) Investing Activities $31,000 USD 100%
Common Stock, Shares Authorized 400,000,000 shares 150%
Common Stock, Shares, Issued 6,768,184 shares -78%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,907,000 USD 97%
Interest Paid, Excluding Capitalized Interest, Operating Activities $937,000 USD -5%
Deferred Tax Assets, Valuation Allowance $77,189,000 USD 32%
Deferred Tax Assets, Gross $81,363,000 USD 34%
Operating Lease, Liability $1,269,000 USD 27%
Depreciation $94,000 USD -15%
Payments to Acquire Property, Plant, and Equipment $31,000 USD -45%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $63,744,000 USD -44%
Lessee, Operating Lease, Liability, to be Paid $1,461,000 USD 15%
Property, Plant and Equipment, Gross $2,620,000 USD 9.7%
Operating Lease, Liability, Current $442,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Two $376,000 USD 23%
Lessee, Operating Lease, Liability, to be Paid, Year One $525,000 USD 323%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $192,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three $277,000 USD -0.72%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $283,000 USD 1.4%
Additional Paid in Capital $516,756,000 USD 18%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets $3,938,000 USD -76%
Deferred Tax Assets, Net of Valuation Allowance $4,174,000 USD 72%
Share-based Payment Arrangement, Expense $2,950,000 USD 5.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%